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Abstract	  
Interspecies	   transmissions	   substantially	   contribute	   to	   the	   epidemiology	   of	   small	   ruminant	   lentiviruses	  
(SRLVs),	   including	   caprine	   arthritis	   encephalitis	   virus	   (CAEV)	   and	   visna-­‐maëdi	   virus.	   However,	  
comprehensive	   studies	  of	   host–virus	   interactions	  during	   SRLV	  adaptation	   to	   the	  new	  host	   are	   lacking.	   In	  
this	  study,	  virological	  and	  serological	  features	  were	  analysed	  over	  a	  6	  month	  period	  in	  five	  sheep	  and	  three	  
goats	   experimentally	   infected	   with	   a	   CAEV	   strain.	   Provirus	   load	   at	   the	   early	   stage	   of	   infection	   was	  
significantly	   higher	   in	   sheep	   than	   in	   goats.	   A	   broad	   antibody	   reactivity	   against	   the	   matrix	   and	   capsid	  
proteins	  was	  detected	  in	  goats,	  whereas	  the	  response	  to	  these	  antigens	  was	  mostly	  type-­‐specific	  in	  sheep.	  
The	  humoral	   response	   to	   the	  major	   immunodominant	  domain	  of	   the	  surface	  unit	  glycoprotein	  was	   type-­‐
specific,	   regardless	  of	   the	  host	  species.	  These	  species-­‐specific	   immune	  responses	  were	  then	  confirmed	   in	  
naturally	   infected	  sheep	  and	  goats	  using	  sera	  from	  mixed	  flocks	   in	  which	   interspecies	  transmissions	  were	  
reported.	  Taken	  together,	  these	  results	  provide	  evidence	  that	  SRLV	  infections	  evolve	  in	  a	  host-­‐dependent	  
manner,	  with	  distinct	  host–virus	   interactions	   in	  sheep	  and	  goats,	  and	  highlight	  the	  need	  to	  consider	  both	  
SRLV	  genotypes	  in	  diagnosis,	  particularly	  in	  sheep.	  
	  	  	  	  The	  GenBank/EMBL/DDBJ	  accession	  numbers	  for	  the	  sequences	  reported	  in	  this	  paper	  are	  JX878404	  and	  
JX878405.	  
Introduction	  
Small	  ruminant	  lentiviruses	  (SRLVs),	  comprising	  caprine	  arthritis-­‐encephalitis	  virus	  (CAEV)	  and	  ovine	  visna-­‐
maëdi	   virus	   (VMV),	   have	   been	   assigned	   to	   five	   distinct	   genetic	   groups	   (A	   to	   E)	   that	   are	   subdivided	   into	  
numerous	  subtypes	  (Reina	  et	  al.,	  2010;	  Shah	  et	  al.,	  2004a).	  Groups	  A	  and	  B	  are	  predominant	  and	  refer	  to	  
VMV-­‐like	  and	  CAEV-­‐like	  strains,	  respectively.	  To	  date,	  group	  A	  includes	  13	  subtypes	  (A1–A13)	  and	  group	  B	  
contains	   only	   three	   subtypes	   (B1–B3).	   This	   high	   genetic	   diversity	   is	   associated	   with	   changes	   in	   the	  
cytopathic	  phenotype,	  cellular	  tropism	  and	  pathogenicity	  of	  SRLV	  strains	  (Angelopoulou	  et	  al.,	  2008;	  Hötzel	  
&	   Cheevers,	   2001;	   Lairmore	   et	   al.,	   1987;	   Oskarsson	   et	   al.,	   2007;	   Quérat	   et	   al.,	   1984).	   In	   addition,	   the	  
antigenic	  cross-­‐reactivity	  between	  SRLV	  groups	  is	  limited	  (Grego	  et	  al.,	  2002,	  2005;	  Mordasini	  et	  al.,	  2006;	  
Olech	  et	  al.,	  2012),	  which	  represents	  a	  diagnostic	  drawback	  (Herrmann-­‐Hoesing	  et	  al.,	  2010;	  Lacerenza	  et	  
al.,	  2006;	  Reina	  et	  al.,	  2009).	  
SRLV	  strains	  have	   long	  been	  considered	  to	  be	  species-­‐specific	  pathogens,	  with	  groups	  A	  and	  B	  associated	  
with	  sheep	  and	  goats,	   respectively.	   It	   is	  presently	  acknowledged	  that	   interspecies	   transmissions	   regularly	  
occur	   in	  both	  directions	   (sheep	   to	   goat	   and	  goat	   to	   sheep)	  under	  natural	   conditions,	   and	  most	   subtypes	  
have	  been	  found	  in	  both	  species	  (Germain	  et	  al.,	  2008;	  Gjerset	  et	  al.,	  2007;	  Grego	  et	  al.,	  2007;	  Pisoni	  et	  al.,	  
2005;	   Shah	   et	   al.,	   2004a,	   b;	   Zanoni,	   1998).	   However,	   the	   underlying	   mechanisms	   and	   consequences	  
associated	  with	  SRLV	  adaptation	  to	  new	  hosts	  following	  interspecies	  transmission	  are	  poorly	  explored	  and	  
understood.	  Because	  SRLV	  strains	  differ	   in	   their	  biological	  properties,	   the	  outcome	  of	   the	   infection	  could	  
vary	  widely.	   For	   instance,	   some	  group	  A	   viruses	   are	  highly	   neurovirulent,	  while	   group	  B	   viruses	   seem	   to	  
have	  a	  propensity	   to	   induce	  arthritis	   (Glaria	  et	  al.,	  2009;	  Oskarsson	  et	  al.,	  2007).	  Recently,	  a	   significantly	  
higher	   rate	   of	   lactogenic	   transmission	   has	   been	   reported	   for	   VMV-­‐like	   viruses	   in	   goats	   co-­‐infected	  with	  
SRLV	  groups	  A	  and	  B	  (Pisoni	  et	  al.,	  2010).	  Several	  lines	  of	  evidence	  indicate	  that	  host	  determinants	  may	  also	  
influence	  the	  outcome	  of	  SRLV	  infection.	  Epidemiological	  studies	  have	  shown	  that	  the	  seroprevalence	  and	  
frequency	  of	  PCR	  detection	  of	  provirus	   from	  blood	  among	   seropositive	  animals	   vary	  between	   sheep	  and	  
goats	  in	  mixed	  flocks	  infected	  by	  a	  single	  viral	  strain	  (Germain	  et	  al.,	  2008;	  Gjerset	  et	  al.,	  2009).	  Moreover,	  
analysis	  of	  the	  humoral	  immune	  response	  in	  naturally	  infected	  animals	  has	  revealed	  that	  the	  spectrum	  of	  
antibody	  reactivity	  is	  higher	  in	  goats	  than	  in	  sheep	  (Grego	  et	  al.,	  2002),	  while	  neutralizing	  activity	  is	  more	  
frequently	   detected	   in	   sheep	   (Narayan	   et	   al.,	   1984;	   Torsteinsdottir	   et	   al.,	   2007).	   These	   observations	  
indicate	  that	  the	  virus	  is	  exposed	  to	  different	  selective	  pressures	  following	  interspecies	  transmission.	  In	  this	  
respect,	  it	  has	  been	  suggested	  that	  adaptation	  of	  CAEV-­‐like	  viruses	  to	  the	  new	  ovine	  host	  is	  associated	  with	  
a	  shift	  of	  the	  viral	  genetic	  and	  phenotypic	  properties	  towards	  those	  of	  VMV-­‐like	  viruses	  (Glaria	  et	  al.,	  2009;	  
Karr	   et	   al.,	   1996).	   These	   findings	   provide	   evidence	   that	   interspecies	   transmissions	   may	   influence	   many	  
aspects	  of	  the	  biology	  of	  SRLV,	  highlighting	  the	  need	  for	  a	  direct	  comparative	  analysis	  of	  SRLV	  infection	  in	  
sheep	  and	  goats	  to	  gain	  a	  better	  understanding	  of	  the	  discrete	  mechanisms	  of	  viral	  adaptation	  to	  the	  new	  
host.	  
In	   this	  study,	   for	   the	   first	   time,	  serological	  and	  virological	  parameters	  during	  the	  early	  stages	  of	   infection	  
were	   compared	   in	   sheep	   and	   goats	   experimentally	   infected	   with	   a	   CAEV	   variant.	   Analysis	   of	   the	   blood	  
proviral	  load	  and	  B-­‐cell	  humoral	  response	  towards	  the	  viral	  structural	  proteins	  revealed	  specific	  host–virus	  
interactions.	  The	  differences	   in	  antibody	  reactivity	  between	  sheep	  and	  goats	  were	  confirmed	   in	  naturally	  
infected	  animals	  from	  mixed	  flocks.	  
Results	  
To	   investigate	   differences	   in	   host–virus	   interactions	   between	   sheep	   and	   goats	   infected	   with	   SRLV,	   the	  
French	   strain	  Agh283	  was	  used	   as	   infecting	   virus	   in	   cross-­‐species	   infections.	   Proviral	   sequences	  of	   strain	  
Agh283	   were	   originally	   detected	   in	   both	   sheep	   and	   goats	   from	   a	   mixed	   flock	   (Germain	   et	   al.,	   2008),	  
indicating	   that	   this	   isolate	   could	   infect	   and	   propagate	   in	   both	   species.	   The	   virus	   was	   isolated	   from	   a	  
seropositive	   sheep	   by	   co-­‐cultivation	   of	   blood	   monocyte-­‐derived	   macrophages	   with	   goat	   synovial	  
membrane	  (GSM)	  cells.	  It	  was	  assigned	  to	  subtype	  B2,	  according	  to	  the	  phylogenetic	  classification	  inferred	  
from	  sequences	  coding	   for	   the	  nucleoprotein	  and	   the	  V1V2	  region	  of	  SU	  protein.	  To	   further	  characterize	  
this	   SRLV	   strain,	   two	   fragments	   encompassing	   the	   nearly	   complete	  MA/CA	   coding	   sequence	   and	   the	   V5	  
region	  of	  SU	  protein	  were	  amplified	  from	  infected	  GSM	  cells,	  cloned	  and	  sequenced.	  As	  shown	  in	  Table	  1,	  
the	  assignment	  of	  strain	  Agh283	  to	  genotype	  B	  was	  also	  strongly	  supported	  by	  the	  similarity	  of	  the	  Gag	  and	  
SU	   immunodominant	   regions	  of	   strain	  Agh283	  with	   those	  of	  CAEV-­‐like	  viruses,	  although	   the	  SU5	  domain	  
exhibited	  substantial	  diversity	  among	  isolates	  within	  each	  genotype,	  supporting	  the	  type-­‐specific	  antibody	  
response	  towards	  this	  immunodominant	  region	  (Carrozza	  et	  al.,	  2009;	  Mordasini	  et	  al.,	  2006).	  Additionally,	  
the	  phenotype	  of	  strain	  Agh283	  was	  examined	   in	  different	  caprine	  cells;	   this	  strain	  established	  persistent	  
infections	  and	  replicated	  to	  moderate	  levels	  in	  macrophages	  and	  GSM	  cells	  with	  formation	  of	  large	  syncytia	  
(>15	   nuclei),	   whereas	   neither	   cytopathic	   effect	   nor	   reverse	   transcriptase	   (RT)	   activity	   was	   detected	   in	  
choroid	   plexus	   (CP)	   cells	   (data	   not	   shown).	   These	   growth	   properties	   led	   to	   the	   classification	   of	   strain	  
Agh283	  as	  a	  slow/low	  virus.	  
	  
*The	  strain	  Agh283	  was	  used	  as	  infecting	  virus.	  Antigens	  of	  strains	  It-­‐Pi1	  and	  It-­‐561	  were	  used	  in	  ELISAs	  based	  on	  the	  P16-­‐P25	  recombinant	  proteins	  
and	   SU5	   synthetic	   peptides.	   Antigens	   of	   strains	   1217	   and	   0016	   were	   used	   in	   ELISAs	   based	   on	   the	   multi-­‐epitope	   SU1/Gag/SU5	   and	   SU1/SU5	  
recombinant	  proteins.	  
Table	  1.	  Sequence	  homology	  of	  Gag	  and	  SU	  immunodominant	  regions	  between	  the	  infecting	  virus	  and	  SRLV	  
strains	  used	  as	  antigens	  in	  ELISA	  tests	  
	  
Kinetics	  of	  seroconversion	  and	  proviral	  detection	  in	  sheep	  and	  goats	  following	  experimental	  infection	  
Three	  goats	  (g47,	  g05	  and	  g62)	  and	  five	  sheep	  (s91,	  s31,	  s36,	  s88	  and	  s32)	  were	  infected	  by	  intratracheal	  
inoculation	  of	   cell	   culture	   supernatant	   containing	  4×102	  TCID50	  of	   strain	  Agh283.	  Three	  goats	  and	   three	  
sheep	   were	   mock-­‐infected	   with	   supernatant	   from	   a	   non-­‐infected	   cell	   culture	   and	   used	   as	   controls.	   All	  
animals	   were	   bled	   at	   regular	   intervals	   over	   a	   6	  month	   period.	   Infection	  was	   first	   assessed	   by	   detecting	  
seroconversion	  using	  a	  whole	  virus	  ELISA	  test	  (Chekit	  CAEV/MVV;	  Idexx	  Laboratories)	  and	  provirus	  in	  blood	  
by	  PCR.	  As	  shown	  in	  Fig.	  1,	  the	  three	  infected	  goats	  seroconverted	  between	  weeks	  3	  and	  7	  post-­‐infection	  
(p.i.)	   and	   remained	   seropositive	   during	   the	   investigated	   period,	   except	   one	   goat	   (g05),	   which	   was	  
transitorily	  negative	  at	  weeks	  5–7	  p.i.	  The	  five	  infected	  sheep	  seroconverted	  between	  weeks	  4	  and	  10	  p.i.,	  
and	   remained	   positive	   during	   the	   whole	   study.	   The	   time	   to	   seroconversion	   did	   not	   significantly	   differ	  
between	   sheep	   and	   goats.	   Infection	   was	   confirmed	   by	   PCR	   detection	   of	   provirus	   from	   blood	   in	   all	  
seropositive	  sheep	  and	  goats	  (Table	  2).	  All	  animals	  became	  PCR	  positive	  between	  weeks	  2	  and	  4	  p.i.,	  except	  
one	   goat	   (g47)	   that	   turned	   PCR	   positive	   at	   week	   7	   p.i.	  While	   the	   time	   to	   become	   PCR	   positive	   did	   not	  
significantly	   differ	   between	   sheep	   and	   goats,	   the	   frequency	  of	   both	  provirus	   detection	   and	  proviral	   load	  
were	  significantly	  higher	  in	  sheep	  than	  in	  goats	  (P<0.0003).	  All	  control	  animals	  remained	  seronegative	  and	  
PCR	  negative	  throughout	  the	  experiment	  (data	  not	  shown).	  
	  
	  Fig.	  1.	  
Kinetics	  of	  seroconversion	  in	  a	  whole	  virus	  ELISA	  of	  goats	  and	  sheep	  experimentally	  infected	  with	  CAEV	  strain	  Agh283.	  Animals	  were	  intratracheally	  
infected	  with	  strain	  Agh283	  and	  sera	  were	  tested	  at	  different	  time	  points	  using	  the	  Chekit	  ELISA	  test.	  The	  bold	  line	  represents	  the	  cut-­‐off	  value	  of	  




Table	  2.	  Blood	  proviral	   load	  (copies	  µg−1	  of	  genomic	  DNA)	   in	  sheep	  and	  goats	  experimentally	   infected	  with	  CAEV	  strain	  Agh283	  <10,	  Samples	  
tested	  in	  triplicate	  consistently	  positive	  by	  real-­‐time	  PCR	  but	  with	  Ct	  values	  above	  40,	  not	  permitting	  a	  precise	  quantification;	  –,	  undetectable;	  NA,	  
not	  available.	  
Antibody	  responses	  to	  SRLV	  structural	  proteins	  in	  experimentally	  infected	  animals	  
The	   kinetics	   of	   antibody	   production	   towards	   the	   matrix	   (MA/P16)	   and	   capsid	   (CA/P25)	   proteins	   was	  
analysed	  by	  ELISA	  using	  the	  previously	  described	  P16-­‐P25	  recombinant	  antigens	  derived	  from	  either	  the	  It-­‐
Pi1	   (CAEV-­‐like)	  or	   It-­‐561	   (VMV-­‐like)	   strains	   (Lacerenza	  et	  al.,	   2006).	  As	   shown	   in	  Fig.	  2,	   all	   infected	  goats	  
seroconverted	  to	  the	  CAEV	  P16-­‐P25	  antigen	  between	  weeks	  3	  and	  6	  p.i.,	  and	  to	  the	  VMV	  P16-­‐P25	  antigen	  
between	  weeks	   3	   and	   8	   p.i.	   Seroconversion	  of	   all	   infected	   sheep	   to	   the	  CAEV	  P16-­‐P25	   antigen	  occurred	  
between	  weeks	  4	  and	  5	  p.i.	  Four	  sheep	  seroconverted	  to	  the	  VMV	  P16-­‐P25	  antigen	  between	  weeks	  6	  and	  
10	  p.i.,	  whereas	  one	   sheep	   (s32)	   remained	  negative	  versus	  VMV	  antigen	   throughout	   the	   study.	  While	  all	  
sera	  of	  sheep	  and	  goats	  showed	  increased	  reactivity	  levels	  that	  stably	  settled	  into	  the	  positive	  range	  in	  the	  
CAEV	   P16-­‐P25	   ELISA,	   they	   displayed	   more	   fluctuating	   kinetics	   of	   reactivity	   in	   the	   VMV	   P16-­‐P25	   ELISA,	  
reaching	  the	  weak	  positive	  range	  (two	  sheep)	  or	  falling	  into	  the	  negative	  range	  (one	  sheep	  and	  two	  goats).	  
These	  results	  suggested	  that	  antibody	  reactivity	  against	  the	  Gag	  proteins	  was	  more	  type-­‐specific	   in	  sheep	  
than	  in	  goats	  during	  the	  early	  stages	  of	  infection.	  
	  Fig.	  2.	  
Kinetics	  and	  patterns	  of	  antibody	  reactivity	  against	  Gag	  epitopes	   in	  goats	  and	  sheep	  experimentally	   infected	  with	  CAEV	  strain	  Agh283.	  Panels	  (a)	  
and	  (b)	  show	  the	  ELISA	  reactivity	  of	  goat	  sera	  against	  CAEV	  (strain	  It-­‐Pi1)	  and	  VMV	  (strain	  It-­‐561)	  P16/P25	  antigens,	  respectively.	  Panels	  (c)	  and	  (d)	  
represent	  the	  ELISA	  reactivity	  of	  sheep	  sera	  against	  CAEV	  (strain	  It-­‐Pi1)	  and	  VMV	  (strain	  It-­‐561)	  P16/P25	  antigens,	  respectively.	  Bold	  lines	  are	  the	  
cut-­‐off	  values	  for	  each	  test.	  g,	  Goat;	  s,	  sheep.	  OD,	  Optical	  density.	  
	  
The	  kinetics	  of	  antibody	  production	  towards	  the	  major	  antigenic	  site	  (SU5)	  of	  the	  surface	  glycoprotein	  was	  
analysed	  by	  ELISA	  using	  synthetic	  peptides	  corresponding	  to	  the	  SU5	  sequence	  of	  the	  aforementioned	  SRLV	  
strains	  ItPi1	  and	  It561.	  As	  shown	  in	  Fig.	  3,	  infected	  goats	  seroconverted	  to	  the	  CAEV	  SU5	  peptide	  between	  
weeks	  3	  and	  8	  p.i.,	  concomitantly	  with	  the	  production	  of	  antibodies	  directed	  against	  the	  Gag	  antigens,	  and	  
remained	  clearly	  positive	  during	  the	  whole	  study.	  All	   infected	  sheep	  produced	  a	  high	  and	  steady	  humoral	  
immune	  response	  against	  the	  CAEV	  SU5	  peptide	  as	  soon	  as	  2–4	  weeks	  p.i.,	  thus	  preceding	  seroconversion	  
to	   the	  Gag	   antigens.	   Conversely,	   only	   two	   animals	   showed	  weak	   and	   transient	   positive	   responses	   in	   the	  
VMV	  SU5	  ELISA,	  one	  goat	  (g05)	  and	  one	  sheep	  (s32)	  being	  positive	  at	  weeks	  1	  and	  4	  p.i.	  and	  weeks	  7–12	  
p.i.,	   respectively.	  Taken	   together,	   these	   results	   indicated	   that	  antibody	   response	  against	   the	  SU5	  domain	  





Kinetics	  and	  patterns	  of	  antibody	  reactivity	  against	  the	  SU5	  immunodominant	  domain	  in	  goats	  and	  sheep	  experimentally	  infected	  with	  CAEV	  strain	  
Agh283.	  Panels	   (a)	  and	   (b)	  show	  the	  ELISA	  reactivity	  of	  goat	  sera	  against	  CAEV	   (strain	   It-­‐Pi1)	  and	  VMV	  (strain	   It-­‐561)	  SU5	  peptides,	   respectively.	  
Panels	  (c)	  and	  (d)	  represent	  the	  ELISA	  reactivity	  of	  sheep	  sera	  against	  CAEV	  (strain	  It-­‐Pi1)	  and	  VMV	  (strain	  It-­‐561)	  SU5	  peptides,	  respectively.	  Bold	  
lines	  are	  the	  cut-­‐off	  values	  for	  each	  test.	  OD,	  Optical	  density;	  g,	  goat;	  s,	  sheep.	  
Spectrum	  of	  antibody	  responses	  to	  SRLV	  structural	  proteins	  during	  natural	  CAEV	  infection	  
To	   confirm	   the	   relationships	   between	   the	   host	   species	   and	   the	   range	  of	   antibody	   reactivity	   towards	   the	  
immunodominant	   epitopes	   of	   the	   MA/CA	   and	   SU	   proteins	   during	   natural	   infection,	   we	   tested	   a	   well-­‐
defined	  panel	  of	  75	  sera	  from	  mixed	  flocks	   in	  which	  sheep	  and	  goats	  were	  found	  to	  be	   infected	  with	  the	  
same	   CAEV	   variants	   (Germain	   et	   al.,	   2008).	   These	   sera,	   including	   45	   sheep	   sera	   and	   30	   goat	   sera,	  were	  
positive	  in	  the	  commercially	  available	  Chekit	  ELISA.	  The	  spectrum	  of	  reactivity	  of	  these	  sera	  was	  assessed	  in	  
ELISA	  using	  two	  sets	  of	  multi-­‐epitope	  recombinant	  antigens.	  The	  SU1/Gag/SU5	  antigens	  contained	  the	  P16-­‐
P25	  precursor	  flanked	  at	  both	  its	  terminal	  ends	  by	  the	  two	  immunodominant	  domains	  (SU1	  and	  SU5)	  of	  the	  
SU	  protein.	  The	  SU1/SU5	  antigens	  only	  contained	  the	  SU	  epitopes	  and	  were	  derived	  from	  the	  previous	  ones	  
by	  removing	  the	  Gag	  domain.	  Each	  set	  of	  antigens	  was	  established	  from	  either	  CAEV	  (strain	  1217)	  or	  VMV	  
(strain	  0016)	  sequences	  belonging	  to	  subtypes	  B2	  and	  A13,	  respectively	  (Olech	  et	  al.,	  2012).	  The	  patterns	  of	  
reactivity	  of	  sera	  from	  experimentally	  infected	  animals	  towards	  these	  antigens	  were	  consistent	  with	  those	  
obtained	  using	  P16-­‐P25	  recombinant	  antigens	  and	  SU5	  peptides	  (Table	  3).	  Indeed,	  sheep	  sera	  reacted	  in	  a	  
type-­‐specific	  manner	  against	  both	   the	  Gag	  and	  SU	   immunodominant	   regions,	  while	  goat	  sera	  exhibited	  a	  
broad	   reactivity	   against	   the	   Gag	   determinants	   and	   a	   type-­‐specific	   response	   against	   the	   SU	   domains.	  
Analysis	   of	   antibody	   responses	   in	   naturally	   infected	   animals	   confirmed	   these	   species-­‐specific	   features	   of	  
the	  B-­‐cell	   immune	   response	   following	  CAEV	   infection.	  As	   shown	   in	   Fig.	   4(a),	   all	   goat	   sera	   reacted	   to	   the	  
CAEV	  SU1/Gag/SU5	  antigen	  and	  most	  of	  them	  (90 %)	  also	  reacted	  to	  the	  homologous	  VMV-­‐like	  antigen.	  In	  
contrast,	  while	  100 %	  of	  sheep	  sera	  reacted	  to	  the	  CAEV	  SU1/Gag/SU5	  antigen,	  only	  a	  few	  of	  them	  (27 %)	  
were	  also	  reactive	  to	  the	  corresponding	  VMV	  antigen.	  The	  reactivity	  to	  the	  SU1/SU5	  antigens	  is	  shown	  in	  
Fig.	  4(b).	  While	  most	  goat	  and	  sheep	  sera	  (97	  and	  73 %,	  respectively)	  reacted	  to	  the	  CAEV-­‐like	  antigen,	  only	  
very	   few	   sera	   reacted	   to	   the	   VMV-­‐like	   antigen,	   with	   13	   and	   7 %	   of	   positive	   sera	   in	   goats	   and	   sheep,	  
respectively.	  The	  reactivity	  of	  sera	  against	  both	  recombinant	  antigens	  was	  significantly	  higher	  in	  goats	  than	  
in	   sheep	   (P<0.0003).	   These	   results	   corroborated	   those	   obtained	   upon	   experimental	   infection,	   showing	   a	  
large	  spectrum	  of	  antibody	  reactivity	  against	  the	  Gag	  proteins	  in	  goats,	  a	  narrow	  range	  of	  reactivity	  against	  
these	  viral	  proteins	   in	  sheep,	  and	  a	  mostly	  type-­‐specific	   immune	  response	  against	  the	  SU	  protein	   in	  both	  
sheep	  and	  goats.	  
	  
Table	  3.	  Seroconversion	  of	  experimentally	  infected	  animals	  in	  ELISA	  using	  Gag/Env	  multi-­‐epitope	  recombinant	  antigens	  
	  
Fig.	  4.	  
Patterns	  of	  antibody	  reactivity	  against	  the	  MA/CA	  and/or	  SU	  epitopes	  in	  naturally	  infected	  sheep	  and	  goats.	  Sera	  from	  sheep	  and	  goats	  from	  mixed	  
flocks	  infected	  with	  single	  CAEV	  strains	  were	  tested	  in	  ELISA	  against	  multi-­‐epitope	  recombinant	  antigens	  containing	  either	  the	  MA/CA	  and	  SU1/SU5	  
epitopes	   (a)	   or	   only	   the	   SU-­‐derived	   epitopes	   (b).	   Both	   sets	   of	   antigens	   were	   established	   from	   either	   CAEV	   (strain	   1217)	   or	   VMV	   (strain	   0016)	  
sequences,	  as	   indicated	  below	  the	  panels.	  Values	  within	   the	  second	  and	   third	  quartiles	  are	  boxed	  and	  medians	  are	   indicated.	  Whiskers	   (vertical	  
bars)	  indicate	  values	  up	  to	  1.5	  box	  lengths	  beyond	  the	  box.	  Values	  outside	  the	  box	  plots	  are	  indicated	  by	  open	  circles.	  Dashed	  lines	  are	  the	  cut-­‐off	  
values	  for	  each	  test.	  OD,	  Optical	  density.	  
Discussion	  
In	   this	   study,	   we	   compared	   serological	   and	   virological	   features	   in	   sheep	   and	   goats	   experimentally	   or	  
naturally	   infected	  with	   the	   same	  CAEV	  variant.	  The	  early	   stages	  of	  experimental	  CAEV	   infection	   in	   sheep	  
were	   characterized	   by	   a	   sustained	   peak	   of	   virus	   replication	   in	   peripheral	   blood	   and	   a	   strong	   and	   steady	  
production	   of	   anti-­‐SU	   antibodies	   which	   preceded	   the	   antibody	   response	   to	   the	  MA	   and	   CA	   proteins.	   In	  
contrast,	  experimental	  CAEV	  infection	  in	  goats	  was	  associated	  with	  a	  low	  provirus	  load	  in	  peripheral	  blood	  
and	   concomitant	  production	  of	   antibodies	   towards	   the	   immunodominant	   epitopes	  of	   the	   viral	   structural	  
proteins	  which	  gradually	  increased	  during	  the	  first	  6	  months	  following	  infection.	  
Experimental	   infection	   with	   SRLV	   was	   characterized	   by	   an	   initial	   burst	   of	   viral	   replication	   within	   a	   few	  
weeks	   associated	  with	   a	   vigorous	   host	   humoral	   response,	   followed	   by	   an	   extended	   period	   of	   restricted	  
replication	   or	   latency	   (Brahic	   et	   al.,	   1981;	   Staskus	   et	   al.,	   1991;	   Vigne	   et	   al.,	   1987).	   The	   underlying	  
mechanisms	   responsible	   for	   the	   striking	  difference	   in	  provirus	   load	  between	   sheep	  and	  goats	  during	   the	  
early	  stage	  of	   infection	  are	  unclear.	   It	   is	  unlikely	  that	  these	  differences	  result	  from	  the	  route	  of	   infection.	  
Intratracheal	   injection	   is	   known	   to	   be	   a	   highly	   efficient	   method	   of	   experimental	   infection	   in	   sheep	  
(Torsteinsdóttir	   et	   al.,	   2003),	   and	  alveolar	  macrophages	  are	  permissive	   cells	   that	   represent	  an	   important	  
viral	   reservoir	   in	   vivo	   (Brodie	   et	   al.,	   1995;	   Gelmetti	   et	   al.,	   2000;	   Luján	   et	   al.,	   1994).	   A	   recent	   study	  
demonstrated	   that	   intratracheal	   injection	   of	   SRLV	   group	   E	   at	   a	   5×105	   TCID50	   infectious	   dose	   led	   to	  
productive	   infections	   in	   all	   inoculated	   goats	   (Reina	   et	   al.,	   2011).	   In	   this	   study,	   the	   fact	   that	   antibody	  
responses	   to	   viral	   structural	   proteins	   in	   goats	   were	   detected	   as	   early	   as	   those	   observed	   in	   sheep	   and	  
increased	  over	  time	  following	  inoculation	  with	  a	  low	  viral	  dose	  (4×102	  TCID50)	  confirmed	  that	  the	  tracheal	  
route	  for	  infection	  is	  efficient	  in	  goats.	  The	  infecting	  virus	  used	  in	  this	  study	  belonged	  to	  SRLV	  subtype	  B2,	  
which	   predominates	   in	   sheep	   flocks	   from	   France	   and	   Italy	   (Germain	  &	   Valas,	   2006;	   Grego	   et	   al.,	   2002).	  
Although	  this	  subtype	  can	  productively	   infect	  goats,	   its	  prevalence	  remains	  higher	   in	  sheep	  than	   in	  goats	  
from	  mixed	  flocks	  (Germain	  et	  al.,	  2008).	  In	  contrast,	  analysis	  of	  infection	  with	  CAEV	  strains	  representative	  
of	   SRLV	   group	   C	   in	   mixed	   flocks	   revealed	   a	   higher	   prevalence	   in	   goats,	   a	   lower	   frequency	   of	   provirus	  
detection	   in	   seropositive	   sheep,	   and	   a	   tendency	   of	   goat	   isolates	   to	   replicate	  more	   efficiently	   in	   cells	   of	  
caprine	   origin	   (Gjerset	   et	   al.,	   2007,	   2009).	   These	   results	   strongly	   suggested	   that	   CAEV	   subtypes	   differ	   in	  
their	  propensity	  to	  spread	  in	  sheep	  and	  goats.	  
In	  addition	  to	  the	  different	  provirus	  loads	  in	  blood,	  the	  kinetics	  of	  antibody	  responses	  to	  the	  viral	  structural	  
proteins	   differed	   in	   sheep	   and	   goats	   following	   experimental	   infection	   with	   subtype	   B2.	   While	   antibody	  
responses	  to	  the	  Gag	  (MA	  and	  CA)	  and	  SU	  proteins	  were	  detected	  at	  the	  same	  time	  in	  infected	  goats,	  in	  all	  
infected	  sheep	  anti-­‐SU	  antibodies	  were	  produced	  at	  a	  high	  titre	  and	  earlier	  than	  those	  directed	  against	  the	  
MA	   and	   CA	   proteins.	   The	   pattern	   of	   the	   immune	   response	   in	   sheep	   contrasted	   with	   those	   previously	  
reported	   in	   sheep	   naturally	   and	   experimentally	   infected	   with	   VMV	   strains,	   where	   the	   Gag	   proteins	   are	  
considered	   to	   be	   the	   first	   antigens	   recognized	   by	   the	   host	   humoral	   response,	   preceding	   the	   SU	   protein	  
(Houwers	  &	  Nauta,	  1989;	  Kajikawa	  et	  al.,	  1990;	  Singh	  et	  al.,	  2006;	  Torfason	  et	  al.,	  1992).	  This	  discrepancy	  of	  
results	   may	   be	   explained	   by	   virus-­‐specific	   properties	   together	   with	   the	   genetic	   background	   of	   animals	  
which	   strongly	   modulates	   the	   immune	   response	   elicited	   after	   SRLV	   infection	   (Fluri	   et	   al.,	   2006).	  
Interestingly,	   it	   has	   been	   shown	   that	   high	   titres	   of	   anti-­‐SU	   antibodies	   associate	   with	   and	   predict	   the	  
severity	  of	  clinical	  signs	  in	  chronically	  infected	  animals,	  and	  that	  viral	  load	  in	  blood	  also	  correlates	  with	  and	  
predicts	  the	  extent	  of	  histological	  lesions	  in	  sheep	  (Herrmann-­‐Hoesing	  et	  al.,	  2009;	  Knowles	  et	  al.,	  1990).	  In	  
the	  case	  of	  primate	  lentivirus	  infections,	  early	  viral	  and	  host	  immune	  events	  can	  predict	  subsequent	  disease	  
progression	  (Lifson	  et	  al.,	  1997;	  Pantaleo	  et	  al.,	  1997;	  Verhofstede	  et	  al.,	  1994).	  Since	  most	  of	  subtype	  B2	  
strains	   are	   pathogenic	   in	   naturally	   infected	   sheep	   (Grego	   et	   al.,	   2002),	   the	   contrasting	   virological	   and	  
serological	  features	  observed	  in	  sheep	  and	  goats	  in	  this	  study	  could	  reflect	  the	  process	  of	  SRLV	  adaptation	  
in	   their	   natural	   hosts.	   Therefore,	   the	   relationships	   between	   either	   the	   provirus	   level	   or	   titre	   of	   anti-­‐SU	  
antibodies	   during	   the	   early	   stages	   of	   infection	   and	   the	   development	   of	   the	   different	   disease	   forms	   are	  
important	  questions	  to	  address	  in	  further	  in	  vivo	  experiments.	  
Our	   comparative	   analysis	   of	   SRLV	   infection	   in	   sheep	   and	   goats	   also	   revealed	   species-­‐specific	   patterns	   of	  
antibody	   reactivity	   to	   the	   immunodominant	   domains	   of	   viral	   structural	   proteins.	  We	   showed	   that	   both	  
sheep	  and	  goats	  produced	  a	  type-­‐specific	  humoral	  response	  to	  the	  SU5	  epitope	  during	  the	  early	  stage	  of	  
infection.	  We	  expanded	  these	  results	   to	  natural	   infection,	  demonstrating	  a	  restricted	  pattern	  of	  antibody	  
reactivity	   to	   the	   SU1	   and	   SU5	  epitopes	  during	   all	   stages	  of	   infection.	   These	   results	  were	   consistent	  with	  
other	   studies	   and	   confirmed	   the	  potential	   use	  of	   the	  major	   SU	   immunodominant	  epitopes	  as	   serotyping	  
tools	   to	   provide	   information	   on	   the	   genotype	   classification	   of	   the	   infecting	   viruses	   (Bertoni	   et	   al.,	   2000;	  
Carrozza	  et	  al.,	  2009;	  Mordasini	  et	  al.,	  2006).	   In	   contrast,	   the	   spectrum	  of	  antibody	   reactivity	   to	   the	  Gag	  
proteins	   clearly	   differed	   between	   the	   two	   species.	   Following	   experimental	   infection,	   cross-­‐reactive	  
antibodies	  recognizing	  Gag	  antigens	  representative	  of	  SRLV	  group	  A	  appeared	  as	  soon	  as	  did	  those	  elicited	  
towards	  the	  infecting	  group	  B	  virus	  in	  all	  goats,	  while	  a	  delayed	  onset	  of	  such	  cross-­‐reactive	  antibodies	  was	  
observed	  in	  all	  sheep	  except	  for	  one	  which	  produced	  only	  type-­‐specific	  antibodies.	  Moreover,	  the	  kinetics	  
of	   humoral	   responses	   to	   the	   heterologous	   antigens	  was	  more	   fluctuating	   during	   the	   6	  month	   period	   of	  
observation,	   suggesting	   that	   these	   species-­‐specific	   patterns	   of	   anti-­‐Gag	   antibodies	  may	   also	   be	   found	   in	  
long-­‐term	  infected	  animals.	  Analysis	  of	  sera	  from	  mixed	  flocks	  in	  which	  sheep	  and	  goats	  were	  infected	  with	  
the	  same	  virus	  confirmed	  that	  most	  sheep	  reacted	  in	  a	  type-­‐specific	  manner,	  while	  goats	  produced	  a	  broad	  
antibody	  reactivity	  to	  these	  Gag	  antigens.	  Several	  studies	  aimed	  to	  determine	  the	  antigenic	  cross-­‐reactivity	  
between	  CAEV	  and	  VMV	  structural	  proteins,	  leading	  to	  discordant	  results.	  Indeed,	  earlier	  studies	  reported	  
that	  CAEV	  and	  VMV	  were	  antigenically	  closely	  related,	  with	  immunologically	  related	  epitopes	  within	  all	  of	  
the	  major	   structural	  proteins,	   including	  Gag	  antigens	   (Gogolewski	  et	  al.,	  1985;	  Rosati	  et	  al.,	  1999).	  These	  
results	  were	  obtained	  using	  either	  sera	  from	  naturally	  infected	  goats	  or	  antisera	  produced	  in	  rabbits,	  goats	  
and	  sheep.	  However,	  sheep	  antisera	  were	   less	   reactive	  against	  heterologous	  antigens	  than	  goat	  antisera.	  
This	  observation	  was	  confirmed	  by	  another	  study	  showing	  that,	  in	  field	  conditions,	  sheep	  sera	  reacted	  in	  a	  
type-­‐specific	  manner	  against	  a	  major	  CA	  epitope,	  while	  most	  of	  the	  goat	  sera	  recognized	  the	  analogous	  CA	  
epitope	   derived	   from	   both	   SRLV	   groups	   A	   and	   B	   (Grego	   et	   al.,	   2002).	   Finally,	   experimental	   infections	   of	  
sheep	  with	  either	  group	  A	  or	  B	  viruses	  clearly	  revealed	  a	  type-­‐specific	  pattern	  of	  antibody	  reactivity	  to	  the	  
MA	  and	  CA	  proteins,	  at	  least	  during	  the	  early	  stages	  of	  infection	  (Lacerenza	  et	  al.,	  2006).	  Here,	  our	  results	  
provide	  evidence	  that	  the	  spectrum	  of	  humoral	  responses	  to	  the	  SRLV	  structural	  proteins	  also	  depends	  on	  
the	  host	  species.	  
In	  conclusion,	  even	   though	   the	  study	  was	  carried	  out	  on	  a	  small	  number	  of	  animals	  and	  requires	   further	  
experiments,	   our	   results	   demonstrated	   that	   specific	   host–virus	   interactions	   involving	   both	   viral	   and	  host	  
determinants	   take	   place	   during	   SRLV	   infection	   in	   sheep	   and	   goats.	   Thus,	   this	   study	   indicates	   that	  
interspecies	   transmissions	   may	   influence	   the	   biology	   of	   SLRV	   infection,	   including	   pathogenicity,	   viral	  
transmission	  and	  diagnosis.	  Notably,	  it	  highlights	  that	  molecular	  and	  serological	  tools	  for	  diagnosis	  of	  SRLV	  
infections	  may	  have	  different	  sensitivity	  in	  sheep	  and	  goats,	  independently	  of	  viral	  diversity.	  
Methods	  
Virus	  and	  cells.	  
The	   infecting	  virus	  corresponded	  to	  the	  French	  ovine	  strain	  Agh283	  (Germain	  et	  al.,	  2008).	  The	  virus	  was	  
isolated	  from	  a	  seropositive	  sheep	  by	  co-­‐cultivation	  of	  blood	  monocyte-­‐derived	  macrophages	  (BMDM)	  with	  
goat	   synovial	  membrane	   (GSM)	  cells,	  passaged	  once	  on	  GSM	  cells	   and	   stored	  at	  −80	   °C	  until	   used.	  Virus	  
infectivity	   titre	   was	   determined	   by	   limited	   dilution	   assay	   and	   formation	   of	   syncytia	   on	   GSM	   cells,	   and	  
expressed	   as	   TCID50.	   The	   growth	   properties	   of	   strain	   Agh283	   were	   examined	   in	   different	   caprine	   cells,	  
including	   BMDM,	   GSM	   and	   choroid	   plexus	   (CP)	   cells.	   GSM	   and	   CP	   cells	   were	   maintained	   in	   Dulbecco’s	  
minimal	  essential	  medium	  supplemented	  with	   l-­‐glutamine	   (2	  mM),	  gentamicin	   (50	  µg	  ml−1)	  and	  5 %	  FBS.	  
BMDM	  were	  maintained	  in	  Roswell	  Park	  Memorial	  Institute	  1640	  medium	  (RPMI	  1640)	  supplemented	  with	  
l-­‐glutamine	  (2	  mM),	  HEPES	  buffer	  (10	  mM),	  2-­‐mercaptoethanol	  (50	  µM),	  gentamicin	  (50	  µg	  ml−1)	  and	  10 %	  
newborn	   calf	   serum.	   Infection	   was	   performed	   onto	   1-­‐week-­‐old	   macrophages	   and	   80 %	   confluent	  
monolayers	  of	  GSM	  and	  CP	  cells,	  and	  virus	  growth	  was	  monitored	  by	  the	  observation	  of	  lysis	  and	  formation	  
of	   giant	   multinucleated	   cells,	   the	   typical	   cytopathic	   effects	   of	   SRLV	   infection,	   and	   by	   measuring	   the	   RT	  
activity	   in	   the	   supernatant	   from	   infected	   cells	   cultures	   (Lenti-­‐RT	   Activity	   kit;	   Cavidi),	   according	   to	   the	  
manufacturer’s	  protocol.	  
PCR	  amplification	  of	  proviral	  DNA.	  
	  Two	  fragments	  spanning	  either	  the	  nearly	  complete	  MA/CA	  coding	  sequence	  (990	  bp)	  or	  the	  V5	  region	  of	  
SU	  protein	   (608	  bp)	  were	  amplified	  by	  PCR	   from	  GSM	  cells	   infected	  by	   strain	  Agh283	  using	  primer	  pairs	  
MA3f/NC3r	  and	  567/564,	  respectively.	  The	  primers	  and	  PCR	  conditions	  used	  were	  as	  described	  previously	  
(Mordasini	   et	   al.,	   2006;	  Olech	   et	   al.,	   2012).	   PCR	   amplicons	  were	   cloned	  with	   the	  Qiagen	   PCR	   cloning	   kit	  
according	  to	  the	  manufacturer’s	  instructions	  and	  then	  sequenced.	  
Experimental	  infection.	  
Eight	  PréAlpes	  cross	  sheep	  and	  six	  Alpine	  goats	  were	  selected	  from	  certified	  SRLV-­‐free	  flocks	  and	  housed	  in	  
level	  2	  containment	  facilities	  at	  the	  experimental	  station	  of	  the	  French	  Agency	  for	  Food,	  Environmental	  and	  
Occupational	   Health	   and	   Safety	   (Anses).	   Animals	   were	   utilized	   in	   compliance	   with	   the	   relevant	   national	  
legislation	   on	   experimental	   animals	   and	   animal	   welfare,	   upon	   authorization	   by	   the	   French	   competent	  
authority.	   At	   6	   months	   of	   age,	   five	   sheep	   and	   three	   goats	   were	   inoculated	   intratracheally	   with	   4×102	  
TCID50	   of	   strain	   Agh283.	   The	   remaining	   animals	   (three	   sheep	   and	   three	   goats)	   were	   inoculated	   with	  
uninfected	   cell	   culture	   supernatant	   and	   used	   as	   negative	   controls.	   Blood	   samples	  were	   collected	   before	  
inoculation,	  weekly	  during	  the	  first	  2	  months	  p.i.,	  and	  then	  at	  weeks	  10,	  12,	  16,	  20	  and	  24	  p.i.	  Infection	  was	  
assessed	  by	  detecting	  SRLV-­‐specific	  antibodies	  in	  ELISA	  and	  provirus	  in	  blood	  by	  PCR.	  
Serological	  diagnosis.	  
Several	  ELISA	  tests	  were	  applied	  to	  detect	  seroconversion	  and	  production	  of	  antibodies	  directed	  against	  the	  
immunodominant	  epitopes	  of	  the	  matrix	  (MA/P16),	  capsid	  (CA/P25)	  and	  surface	  unit	  (SU/gp135)	  proteins	  
in	   experimentally	   infected	   animals.	   Seroconversion	   was	   detected	   using	   a	   commercially	   available	   whole	  
virus	   ELISA	   (w-­‐ELISA)	   (Chekit;	   Idexx	   Laboratories),	   according	   to	   the	   manufacturer’s	   instructions.	   The	  
production	  of	  antibodies	  directed	  against	  MA	  and	  CA	  proteins	  was	  monitored	  using	  a	  previously	  described	  
ELISA	   test	   based	   on	   P16-­‐P25	   recombinant	   antigens	   carrying	   the	   MA	   protein	   and	   the	   immunodominant	  
subunit	  of	  CA	  (Lacerenza	  et	  al.,	  2006).	  Antibodies	  directed	  against	  the	  major	  antigenic	  site	  (SU5)	  of	  the	  SU	  
protein	   were	   detected	   using	   synthetic	   peptides	   corresponding	   to	   the	   25	   aa,	   complete	   SU5	   domain,	   as	  
previously	  described	   (Carrozza	  et	   al.,	   2009).	   Each	   set	  of	   antigens	   (P16-­‐P25	   recombinant	  protein	   and	   SU5	  
peptides)	  was	  established	  from	  sequences	  derived	  from	  either	  It-­‐Pi1	  (CAEV-­‐like)	  or	  It-­‐561	  (VMV-­‐like)	  strains	  
(Grego	  et	  al.,	  2002).	  Finally,	  sera	  from	  either	  experimentally	  or	  naturally	  infected	  animals	  were	  tested	  in	  an	  
indirect	   ELISA	  based	  on	  Gag	   and/or	   Env	  multi-­‐epitope	   recombinant	   antigens	   (Olech	  et	   al.,	   2012).	   Briefly,	  
two	   sets	   of	   antigens	  were	   used,	   the	   SU1/GAG/SU5	   antigens	   containing	   the	   nearly	   complete	  MA	   and	   CA	  
domains	  fused	  to	  the	  SU1	  and	  SU5	  antigenic	  sites	  of	  the	  SU,	  and	  the	  SU1/SU5	  antigens	   in	  which	  the	  Gag	  
domain	  was	  removed.	  Once	  again,	  each	  set	  of	  antigens	  was	  derived	  from	  either	  CAEV-­‐like	  (strain	  1217)	  or	  
VMV-­‐like	  (strain	  0016)	  sequences.	  The	  three	  in-­‐house	  ELISA	  tests	  were	  carried	  out	  as	  described	  previously,	  
except	   that	   the	   same	   peroxidase-­‐conjugated	   anti-­‐goat/sheep	   IgG	   mAb	   (Sigma)	   was	   used	   as	   secondary	  
antibody	   in	   all	   tests.	   The	   reactivity	   of	   each	   serum	  was	   calculated	   by	   subtracting	   the	   absorbance	   against	  
negative	  control	  antigen	  (water).	  The	  cut-­‐off	  values	  of	  P16-­‐P25	  and	  SU5	  ELISA	  tests	  were	  determined	  as	  the	  
mean	  absorbance	  of	  negative	  sera	  plus	  threefold	  sd.	  The	  cut-­‐off	  value	  of	  SU1/GAG/SU5	  and	  SU1/SU5	  ELISA	  
tests	  was	  set	  at	  an	  OD	  of	  0.4,	  as	  previously	  determined	  (Olech	  et	  al.,	  2012).	  
Proviral	  load	  quantification.	  
Blood	  samples	  were	  drawn	  into	  EDTA-­‐coated	  tubes	  and	  genomic	  DNA	  was	  isolated	  using	  the	  DNeasy	  tissue	  
kit	  (Qiagen)	  according	  to	  the	  manufacturer’s	  instructions.	  Proviral	  load	  was	  determined	  with	  a	  quantitative	  
real-­‐time	   PCR	   assay.	   Quantification	   was	   based	   on	   amplification	   of	   a	   96	   bp	   fragment	   located	   in	   the	   CA	  
coding	   region	   using	   specific	   primers	   AghGag5rt:	   5ʹ′-­‐GCTAACATGGATCAAGCAAGACA-­‐3ʹ′	   and	   AghGag3rt:	   5ʹ′-­‐
CATAGGGTTTCCTGGTCTATGAGA-­‐3ʹ′.	   All	   real-­‐time	   PCRs	  were	   performed	  with	   a	   CFX	   system	   (Bio-­‐Rad)	   and	  
contained	  9	  µl	  extracted	  DNA	  and	  300	  nM	  of	  each	  primer	   in	  20	  µl	  of	  1×	  buffer	  SsoAdvanced	  SYBR	  Green	  
Supermix	  (Bio-­‐Rad).	  The	  amplification	  protocol	  consisted	  of	  an	  initial	  denaturation	  step	  at	  95	  °C	  for	  3	  min	  to	  
activate	   the	  HotStart	   Taq	  DNA	  polymerase	   followed	  by	   45	   cycles	   of	   95	   °C	   for	   5	   s	   and	  57	   °C	   for	   30	   s.	   To	  
confirm	  the	  specificity	  of	  each	  PCR	  product,	  a	  melting	  curve	  analysis	  was	  carried	  out	  immediately	  after	  the	  
amplification	   from	  55	   to	  95	   °C	   in	  0.5	   °C	   increments.	  All	   samples	  were	  analysed	   in	   triplicate.	  The	  provirus	  
copy	  number	  was	  determined	  by	  comparison	  with	  an	  external	  standard	  curve	  and	  expressed	  as	  copies	  µg−1	  
of	  genomic	  DNA.	  
The	  DNA	  standards	  corresponded	  to	  10-­‐fold	  serial	  dilutions	  (107–100	  copies)	  of	   linearized	  plasmid	  pDrive	  
Cloning	   vector	   (Qiagen)	   containing	   the	   990	   bp	   gag	   fragment	   of	   strain	   Agh283.	   The	   PCR	   efficiency	   and	  
correlation	   coefficient	  were	  96.8	  and	  0.996,	   respectively,	   and	   the	  assay	  was	  able	   to	  amplify	   at	   least	  one	  
replica	  sample	  of	  the	  low	  copy	  standards	  (>10	  copies).	  
Statistical	  analysis.	  
Comparison	   of	   virological	   and	   serological	   parameters	   between	   sheep	   and	   goats	   was	   performed	   using	   a	  
non-­‐parametric	  Mann–Whitney	  U-­‐test	  with	  Statistica	  software	  (StatSoft	  France,	  version	  10).	  
Nucleotide	  sequence	  accession	  numbers.	  
The	  nucleotide	  sequences	  of	  the	  gag	  and	  env	  sequences	  of	  CAEV	  strain	  Agh283	  used	  as	  infecting	  virus	  were	  
deposited	  in	  the	  GenBank	  database	  under	  accession	  numbers	  JX878404	  and	  JX878405,	  respectively.	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